null
SMILES: Fc1cc(OCC2CCNCC2)cc2nc(CSC3CCOCC3)[nH]c(=O)c12
InChI Key: InChIKey=YYQHGXMWWCGFNC-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein mono-ADP-ribosyltransferase PARP14 (Homo sapiens (Human)) | BDBM434485 (US10562891, Example 399 | US11008308, Example 399) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Ribon Therapeutics Inc. US Patent | Assay Description Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati... | US Patent US11008308 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein mono-ADP-ribosyltransferase PARP14 [1611-1801] (Homo sapiens (Human)) | BDBM434485 (US10562891, Example 399 | US11008308, Example 399) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Ribon Therapeutics Inc. US Patent | Assay Description Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati... | US Patent US10562891 (2020) BindingDB Entry DOI: 10.7270/Q290265W | |||||||||||
More data for this Ligand-Target Pair |